# OnCo record lb1410 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lb1410/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lb1410" ;
  schema:name "LB1410"@en ;
  schema:description "LB1410 is an experimental bispecific antibody from L & L Bio, Ningbo, China in phase 2 trials, aimed at PD-1 and TIM-3."@en ;
  schema:url <https://onco.cc/drugs/lb1410/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=LB1410> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "bispecific antibody" ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/tim3/> ;
  onco:companies <https://onco.cc/companies/hutchmed/> ;
  onco:trials <https://onco.cc/trials/nct06468358/> .